IsoRay (ISR) Announces cancer Treatment Utilizing Cesium-131 at Brain Tumor Biotech Summit

Published Date: Jun 2015

The Brain Tumor Biotech Summit 2015 , sponsored by the Brain Tumor Biotech Center at The Feinstein Institute for Medical Research and Voices Against Brain Cancer. 

IsoRay, Inc a medical technology company and innovator in seed brachytherapy and medical radioisotope applications recently hared published results and major medical institutions' experiences to date utilizing Cesium-131 for brain tumors on the above forum.

According to IsoRay CEO Dwight Babcock "With our broader reach and our newly published study results, the medical community is becoming more aware of the innovative alternative our Cesium-131 products can offer to patients." This will certainly help in the commercialization of the Cesium industry globally and especially in China. The company is the prime manufacturer of Cesium-131 and the revolutionary brachytherapy therapy is one of the most important development in internal radiation therapy to occur in a period of two decades.

Cesium-131, unique capabilities such as high energy in compact form and its 9.7 day half-life enables the compound to be used for precise treatment of different types of cancers.

In consistent with FDA norms, Cesium-131 holds a CE mark for international sales in seed form for the treatment of different types of cancer such as brain cancer, lung cancer, colorectal cancer, prostate cancer, ocular melanoma cancer, head and neck cancer,  gynecologic cancer,. The treatment can be done using several delivery methods such as single seed applicators, implantable strands and seed sutured mesh.

Also Cesium has characteristic photo emissive properties which makes cesium to have widespread applications in night-vision equipment, television image devices, solar photovoltaic cells, and other types of photoelectric cells. Leading manufacturers are devising business plans and marketing strategies to commercialize the production of cesium. There are many reports in the market which track the development and growth trends in cesium industry. Recently, Prof Research Reports has added a report titled "Market Research Report on Global and Chinese Cesium Industry, 2009-2019".

The report makes a comprehensive study of key market drivers and restraints, detailed market segmentation, competitive analysis and market strategies of leading market players in terms of growth prospects. The report offers an insight into the market size and share of major buyers and suppliers along with current market dynamics.

 

Share This News
facebooktwitterlinkedingoogleplusstumbleuponreddit
24/7 Customer Support
check Have questions?
Direct
+1-971-202-1575
Toll Free
+1(855)711-1555 or2
email help@profresearchreports.com
Market Research

Prof Research Report is a high end market research & consulting firm that offers current and future market intelligence across 30 industrial verticals such as energy, new materials, transportation, daily consumer goods, chemicals, etc through is quality database. Prof Research Report has successfully utilized technology to manage complex and massive market related database, which offers research reports of high analytical value. Prof Research Report’s aim is to help our clients in achieving sustainable growth by providing insightful and qualitative research reports. Our research reports help our clients to achieve the competitive edge in the market.

Vision:

To be a world class provider of market research reports.

Mission:

To create a database of reliable and accurately analyzed report and be the decision making support for our clients.

CONTACT 5320 SW MACADAM AVENUE, SUITE 100, PORTLAND, OR 97239, UNITED STATES. © 2016. ALL RIGHTS RESERVED PROF RESEARCH REPORTS.